Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.

Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.

Item
http://www.wikidata.org/entity/Q38157034
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patientsLoss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3.Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy.Angiogenesis inhibitors in tackling recurrent glioblastoma.Monoamines in Glioblastoma: complex biology with therapeutic potential.In Vitro Assays for Endothelial Cell Functions Required for Angiogenesis: Proliferation, Motility, Tubular Differentiation, and Matrix Proteolysis.
P2860

Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.

Item
http://www.wikidata.org/entity/Q38157034
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.
@en
type
label
Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.
@en
prefLabel
Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.
@en
P2093
P2860
P304
P31
P356
10.1586/14737175.2013.856264
P433
P478
P50
P577
P698